Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Physiol Pharmacol ; 55(4): 823-36, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15613746

ABSTRACT

The role of nitric oxide (NO) in the etiology of ulcerative colitis is controversial with reports of the improvement and aggravation of colonic lesions by inducible NO synthase (iNOS) inhibitors. In the present study, we compared the effect of the selective iNOS inhibitor aminoguanidine and the nonselective NOS inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) on a dextran sulfate sodium (DSS)-induced model of colitis in rats. Experimental colitis was induced by a 3% DSS-solution added to drinking water for 7 days. Aminoguanidine (5 approximately 20 mg/kg) and L-NAME (10 mg/kg) were administered p.o. twice daily for the first 3 days, the last 3 days or all 6 days of DSS treatment. Body weight and severity of colitis (diarrhea, bloody feces) were observed over a period of 7 days. DSS treatment resulted in severe colonic lesions, accompanied by diarrhea, bloody feces, decrease of body weight and colon shortening. All of the parameters investigated improved significantly with aminoguanidine treatment at 20 mg/kg for 6 days or the last 3 days of DSS-treatment, but L-NAME did not significantly affect the colitis during these periods. When L-NAME or aminoguanidine was given in the first 3 days of DSS treatment, the colonic lesions were slightly aggravated by L-NAME but not affected by aminoguanidine. The expression of iNOS mRNA was observed from the 3(rd) day of DSS treatment. These results suggested that endogenous NO exerts a biphasic influence on DSS-induced colitis, depending on the NOS isoenzyme; a beneficial effect of NO derived from constitutive NOS and a detrimental effect of NO produced by iNOS in the development of colitis.


Subject(s)
Colitis/chemically induced , Colitis/metabolism , Dextran Sulfate/toxicity , Nitric Oxide/physiology , Animals , Colitis/prevention & control , Guanidines/pharmacology , Guanidines/therapeutic use , Male , NG-Nitroarginine Methyl Ester/pharmacology , NG-Nitroarginine Methyl Ester/therapeutic use , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/biosynthesis , Rats
2.
Toxicol In Vitro ; 16(6): 705-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12423653

ABSTRACT

Gallic acid and its alkylesters, polyphenolic compounds with antioxidative activity, acted as a prooxidant causing a copper-dependent DNA damage. Treatment of DNA from plasmid pBR322 and calf thymus with gallic acid plus copper ion caused strand scission and the formation of 8-hydroxy-2'-deoxyguanosine in DNA. Addition of catalase protected DNA from the gallic acid/copper-dependent strand breaks and the formation of 8-hydroxy-2'-deoxyguanosine, indicating that hydroxyl radical may participate in the DNA damage. Ethyl-, propyl- and butylgallates showed only a little DNA damage. Octyl- and laurylgallates caused negligible damage of DNA. DNA strand breaks and formation of 8-hydroxy-2'-deoxyguanosine were closely related to the reduction of copper by gallate compounds. These results imply that cuprous ion reduced by gallate derivatives may play a key role in the oxidative cleavage of DNA and the formation of base adduct. The cytotoxic effect of gallate compounds can be explained by their prooxidant action dependent on the reducing activity.


Subject(s)
Copper/adverse effects , DNA Damage , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/chemistry , Gallic Acid/pharmacology , Oxidants/pharmacology , 8-Hydroxy-2'-Deoxyguanosine , Animals , Cattle , DNA Adducts , Esters , Gallic Acid/analogs & derivatives , Plasmids , Thymus Gland/cytology
3.
Biometals ; 14(2): 181-5, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11508851

ABSTRACT

The addition of aluminum-maltol complex to PC12D cells induced a time-dependent and concentration-dependent growth inhibition as well as cell death, whereas aluminum chloride or maltol alone did not affect the viability of PC12D cells. Apoptosis of differentiated PC12D cells was assessed by using terminal deoxynucleotidyltransferase-mediated 2'-deoxyuridine-5'-triphosphate nick end labeling (TUNEL) technique to detect DNA strand breaks in situ. The number of TUNEL-positive cells treated with aluminum-maltol increased with time in the treatment cultures. The ability of aluminum ion to elevate intracellular reactive oxygen species was determined by fluorescence in PC12D cells loaded with the oxidant-sensitive dye 2',7'-dichlorofluorescin diacetate. Aluminum ion incorporated to PC 12D cells causes apoptotic cell death by enhancing the generation of reactive oxygen species.


Subject(s)
Aluminum/pharmacology , Apoptosis/drug effects , Pyrones/pharmacology , Aluminum/adverse effects , Animals , Apoptosis/physiology , Dose-Response Relationship, Drug , Humans , In Situ Nick-End Labeling , Nerve Growth Factor/pharmacology , PC12 Cells , Rats , Reactive Oxygen Species/metabolism , Time Factors
4.
Biometals ; 12(3): 237-40, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10581687

ABSTRACT

Prooxidant nature of aluminum ion was analyzed in relation to iron coordination. Aluminum ion effectively enhanced the formation of thiobarbituric acid-reactive substances as a marker of lipid peroxidation of microsomes from rat liver under the acidic conditions, and this metal further attenuated the antioxidant action of flavonoids such as quercetin and baicalein under neutral conditions. Autooxidation of ferrous ion was markedly inhibited by aluminum ion. Aluminum can act as a prooxidant by stabilizing reduced iron the initiating species for lipid peroxidation, and by inhibiting the antioxidant action of flavonoid.


Subject(s)
Aluminum/pharmacology , Flavonoids/pharmacology , Iron/pharmacology , Lipid Peroxidation/drug effects , Reactive Oxygen Species/physiology , Aluminum/metabolism , Animals , Hydrogen-Ion Concentration , Microsomes, Liver/drug effects , Microsomes, Liver/metabolism , Rats , Reactive Oxygen Species/metabolism , Time Factors , Zinc/pharmacology
5.
Biochim Biophys Acta ; 1252(2): 185-8, 1995 Oct 25.
Article in English | MEDLINE | ID: mdl-7578221

ABSTRACT

Amino-acid sequence of kynureninase purified from rat liver cytosol was determined by an amino-acid sequencer. The enzyme was degraded to small peptides with cyanogen bromide, TPCK-trypsin, endoproteinase Glu-C, lysyl endoprotease and alpha-chymotrypsin. The enzyme subunit consisted of 464 amino acids, and the molecular weight of subunit was determined to be 52,510. The coenzyme pyridoxal phosphate-binding residue was lysine of which position was 276, and the N-terminal residue was N-acetylmethionine. The homology search between this enzyme and the other pyridoxal phosphate-dependent enzymes showed that kynureninase was similar to mitochondrial aspartate aminotransferase, and also to cystathionine gamma-synthase and gamma-lyase to a lesser extent.


Subject(s)
Hydrolases/isolation & purification , Liver/enzymology , Amino Acid Sequence , Animals , Binding Sites , Cyanogen Bromide , Cytosol/enzymology , Hydrolases/chemistry , Male , Molecular Sequence Data , Peptide Fragments/chemistry , Rats , Rats, Wistar , Sequence Alignment
6.
J Nutr ; 121(9): 1366-73, 1991 Sep.
Article in English | MEDLINE | ID: mdl-1880614

ABSTRACT

We examined the change in glutathione metabolism in vitamin B-6-deficient rats. Vitamin B-6-deficient rats were fed a vitamin B-6-deficient diet containing 0.56% methionine and 0.075% cystine for 8 wk. Controls were fed an identical diet supplemented with 10 mg pyridoxine hydrochloride/kg diet. Glutathione concentrations in each organ examined were similar in control and vitamin B-6-deficient rats, and the values were comparably lower after intraperitoneal injection of diethylmaleate. However, buthionine sulfoximine caused a significantly greater decrease in glutathione levels in the liver and lungs of vitamin B-6-deficient rats relative to controls. Glutathione peroxidase activity in the liver of vitamin B-6-deficient rats was higher than in control animals; however, glutathione transferase activity in tissues other than liver of vitamin B-6-deficient rats was higher than in the controls. The activities of gamma-glutamyl-transferase in the liver and spleen of vitamin B-6-deficient rats were significantly lower than control values. The holoenzyme activities of cystathionine beta-synthase and cystathionine gamma-lyase in the liver of vitamin B-6-deficient rats were markedly reduced. These findings indicate that although the activities of enzymes that synthesize cysteine from methionine were decreased by vitamin B-6 deficiency, the level of synthesis and supply of cysteine in vitamin B-6-deficient rats were sufficient to maintain the same glutathione level as in controls, and that glutathione utilization in the liver was accelerated by vitamin B-6 deficiency.


Subject(s)
Cystine/administration & dosage , Glutathione/metabolism , Methionine/administration & dosage , Vitamin B 6 Deficiency/metabolism , Animals , Body Weight , Cystine/metabolism , Diet , Glutathione/pharmacokinetics , Glutathione Reductase/metabolism , Male , Methionine/metabolism , Pyridoxine/administration & dosage , Rats , Rats, Inbred Strains , Tissue Distribution
7.
Adv Exp Med Biol ; 294: 523-6, 1991.
Article in English | MEDLINE | ID: mdl-1772086

ABSTRACT

1) In Mg-deficient rats, kynureninase activity is decreased. 2) p-Hydroxyphenylpyruvate inhibits kynureninase activity. 3) -SH groups in the apoenzyme of kynureninase play a very important role in the enzymatic reaction. 4) 3-Hydroxykynurenine may be a very important regulative metabolite in the 3-hydroxykynurenine----xanthurenic acid pathway.


Subject(s)
Hydrolases/metabolism , Kynurenine/analogs & derivatives , Xanthurenates/metabolism , Animals , Apoenzymes/metabolism , Benzothiazoles , Cysteine/analogs & derivatives , Cysteine/pharmacology , Dithionitrobenzoic Acid/pharmacology , Dithiothreitol/pharmacology , Enzyme Activation/drug effects , Hydrolases/antagonists & inhibitors , Kynurenine/metabolism , Liver/enzymology , Magnesium/metabolism , Male , Phenylpyruvic Acids/pharmacology , Pyridoxal Phosphate/pharmacology , Rats , Rats, Inbred Strains , Tryptophan/metabolism , Tyrosine/pharmacology
8.
J Nutr Sci Vitaminol (Tokyo) ; 35(2): 111-22, 1989 Apr.
Article in English | MEDLINE | ID: mdl-2732805

ABSTRACT

Normal and vitamin B6-deficient rats received an intraperitoneal injection of 30 mg/100g of body wt, and the contents of metabolites in kidney or plasma and the related enzyme activities in kidney were determined. The contents of kynurenine and 3-hydroxykynurenine in B6-deficient rat plasma and kidney were much higher than those in normal rat. The changes of those contents in plasma were parallel to those in kidney, but not in liver. The contents of kynurenic acid and xanthurenic acid in B6-deficient liver, plasma, and kidney were also much higher than those in normal rats. However, the changes of those contents in plasma were parallel to those in liver, but not in kidney. Xanthurenic acid and kynurenic acid accumulated to a much greater extent in kidney than in plasma and liver. Kidney kynureninase activity was very low, but kynurenine aminotransferase activities were very high. These observations indicated that the production of xanthurenic acid after tryptophan injection was favorable in B6-deficient kidney with respect to enzyme activities and substrate concentrations, and suggested that kidney took up kynurenine or 3-hydroxykynurenine from blood and after conversion of them it excreted xanthurenic or kynurenic acid into urine.


Subject(s)
Kynurenine/metabolism , Lyases , Tryptophan/administration & dosage , Vitamin B 6 Deficiency/metabolism , Xanthurenates/metabolism , Animals , Hydrolases/metabolism , Kidney/enzymology , Kynurenic Acid/analysis , Kynurenine/analogs & derivatives , Liver/analysis , Male , Rats , Rats, Inbred Strains , Spectrometry, Fluorescence , Transaminases/metabolism , Tryptophan/blood
9.
J Nutr Sci Vitaminol (Tokyo) ; 34(1): 79-84, 1988 Feb.
Article in English | MEDLINE | ID: mdl-3392610

ABSTRACT

Urinary and renal inhibitory activities of calcium oxalate monohydrate crystal growth in normal or vitamin B6-deficient rats were investigated. Renal inhibitory activity in vitamin B6-deficient rats was lower than that in normal rats. Renal inhibitory activity in vitamin B6-deficient rats was about 74% of normal level. Urinary inhibitory activity did not show a significant difference between normal and vitamin B6-deficient rats.


Subject(s)
Calcium Oxalate/antagonists & inhibitors , Glycoproteins/analysis , Kidney/analysis , Vitamin B 6 Deficiency/metabolism , Animals , Calcium Oxalate/analysis , Calcium Oxalate/urine , Glycoproteins/urine , Male , Rats , Rats, Inbred Strains , Vitamin B 6 Deficiency/urine
10.
Life Sci ; 42(16): 1565-70, 1988.
Article in English | MEDLINE | ID: mdl-3352468

ABSTRACT

The calcium uptake into renal brush border membrane vesicles, which has been purified from normal or vitamin B6 deficient rat renal cortex by calcium precipitation, was investigated. The values of Km and Vmax were determined to be 1.89 mM and 4.26 nmol of Ca2+/mg of protein per 20s in vitamin B6 deficient rats, respectively. This Vmax was lower than that of normal rats. The chemical compositions of renal brush border membranes did not display a difference in normal and vitamin B6 deficient rats. The amount of brush border membranes isolated from 1 gram of renal cortex in vitamin B6 deficient rats was less than in normal rats.


Subject(s)
Calcium/pharmacokinetics , Kidney Cortex/ultrastructure , Vitamin B 6 Deficiency/metabolism , Animals , Kidney Cortex/metabolism , Male , Microvilli/metabolism , Rats , Rats, Inbred Strains
11.
Biochem J ; 227(2): 537-44, 1985 Apr 15.
Article in English | MEDLINE | ID: mdl-2988502

ABSTRACT

Pyridoxal kinase was purified 4760-fold from rat liver. The Km values for pyridoxine and pyridoxal were 120 and 190 microM respectively, and pyridoxine showed substrate inhibition at above 200 microM. Pyridoxamine 5-phosphate oxidase was also purified 2030-fold from rat liver, and its Km values for pyridoxine 5-phosphate and pyridoxamine 5-phosphate were 0.92 and 1.0 microM respectively. Pyridoxine 5-phosphate gave a maximum velocity that was 5.6-fold greater than with pyridoxamine 5-phosphate and showed strong substrate inhibition at above 6 microM. Among the tryptophan metabolites, picolinate, xanthurenate, quinolinate, tryptamine and 5-hydroxytryptamine inhibited pyridoxal kinase. However, pyridoxamine 5-phosphate oxidase could not be inhibited by tryptophan metabolites, and on the contrary it was activated by 3-hydroxykynurenine and 3-hydroxyanthranilate. Regarding the metabolism of vitamin B-6 in the liver, the effects of tryptophan metabolites that were accumulated in vitamin B-6-deficient rats after tryptophan injection were discussed.


Subject(s)
Liver/enzymology , Oxidoreductases Acting on CH-NH Group Donors/metabolism , Phosphotransferases/metabolism , Pyridoxal Kinase/metabolism , Pyridoxaminephosphate Oxidase/metabolism , Tryptophan/metabolism , Xanthurenates , Animals , Kinetics , Kynurenic Acid/analogs & derivatives , Kynurenic Acid/pharmacology , Male , Picolinic Acids/pharmacology , Pyridoxal Kinase/isolation & purification , Pyridoxaminephosphate Oxidase/isolation & purification , Quinolinic Acid , Quinolinic Acids/pharmacology , Rats , Rats, Inbred Strains , Tryptamines/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...